SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Cheesehead who wrote (61061)8/30/2000 10:05:52 PM
From: asker2  Read Replies (2) of 150070
 
Cheese, I don't know...but...check this...

personaly I think DNAP will hit .50
by the end of the week...

a little home work from RB...

-------------------------------------------------
By: mbeale4300 $$$$
Reply To: 8244 by VultureCircling $$$
Wednesday, 30 Aug 2000 at 9:47 PM EDT
Post # of 8255

For those who are concern about the Large Number of Outstanding Shares, and Huge
Float (As I WAS.), rest easy.
The company has stated numerous times that a R/S is out of the question near term. It is
not unusual for companies to thrive on large numbers, even numbers that make ours look
tiny. This is what I discoverd while doing some DD on Outstanding Shares and Float.

host.cnbc.com

host.cnbc.com

More: S/O FLOAT

COLGATE-PALMOLIVE COMPANY (CL) 574.4M 557.1M
NORTEL NETWORKS (NT) 2.90 BILLION 2.87B
CISCO SYSTEMS (CSCO) 7.02 BILLION 6.88B
AVON PRODUCTS (AVP) 237.4M 175.7M
CLOROX COMPANY (CLX) 234.7M 169.0M
SUM MICROSYSTEMS (SUNW) 1.59 BILLION 1.54B
GILLETTE (G) 1.05 BILLION 905.6M
JDS UNIPHASE (JDSU) 782.1M 571.4M
LIMITED INC (LTD) 431.6M 319.4M

What about BioTechs you say......
IMMUNEX (IMNX) 502.9M 176.0M
MEDIMMUNE INC (MEDI) 209.8M 163.7M
BIOGEN INC (BGEN) 148.0M 142.1M

-Only the top three most active BioTech stocks on the market
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext